These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2825900)
21. Binding of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine to intact platelets and platelet membranes. Valone FH Methods Enzymol; 1992; 215():224-8. PubMed ID: 1331707 [No Abstract] [Full Text] [Related]
22. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697 [TBL] [Abstract][Full Text] [Related]
23. Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia. Meade CJ; Heuer H; Kempe R Biochem Pharmacol; 1991 Mar; 41(5):657-68. PubMed ID: 1847810 [No Abstract] [Full Text] [Related]
24. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis. Gill P; Jindal NL; Jagdis A; Vadas P J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949 [TBL] [Abstract][Full Text] [Related]
25. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Tahraoui L; Floch A; Mondot S; Cavero I Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653 [TBL] [Abstract][Full Text] [Related]
26. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia. Lopez Diez F; Nieto ML; Fernandez-Gallardo S; Gijon MA; Sanchez Crespo M J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models. Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352 [TBL] [Abstract][Full Text] [Related]
28. PAF-acether transfer activity in HL-60 cells is induced during differentiation. Lumb RH; Record M; Ribbes G; Pool GL; Terce F; Chap H Biochem Biophys Res Commun; 1990 Sep; 171(2):548-54. PubMed ID: 2169726 [TBL] [Abstract][Full Text] [Related]
29. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. Herbert JM; Laplace MC; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264 [TBL] [Abstract][Full Text] [Related]
30. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. Herbert JM; Laplace MC; Cailleau C; Maffrand JP J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255 [TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor-binding protein in human serum. Matsumoto M; Miwa M Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():705-6. PubMed ID: 3004155 [TBL] [Abstract][Full Text] [Related]
32. Characterization of platelet-activating factor (PAF) receptor in the rat brain. Bito H; Kudo Y; Shimizu T J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241 [TBL] [Abstract][Full Text] [Related]
33. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624 [TBL] [Abstract][Full Text] [Related]
34. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Montrucchio G; Alloatti G; Tetta C; De Luca R; Saunders RN; Emanuelli G; Camussi G Am J Physiol; 1989 Apr; 256(4 Pt 2):H1236-46. PubMed ID: 2539755 [TBL] [Abstract][Full Text] [Related]
35. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. Hwang SB J Lipid Mediat; 1990; 2(3-4):123-58. PubMed ID: 1966805 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Ring PC; Seldon PM; Barnes PJ; Giembycz MA Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515 [TBL] [Abstract][Full Text] [Related]
37. Properties of the guinea-pig lung platelet-activating factor receptor encoded by the cloned cDNA. Honda Z; Nakamura M; Seyama Y; Shimizu T J Lipid Mediat; 1992; 5(2):105-7. PubMed ID: 1326344 [TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor in the CNS. Maclennan KM; Smith PF; Darlington CL Prog Neurobiol; 1996 Dec; 50(5-6):585-96. PubMed ID: 9015828 [TBL] [Abstract][Full Text] [Related]
39. [Effects of platelet activating factor on blood platelets]. Fu JM Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618 [No Abstract] [Full Text] [Related]
40. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. Graham RM; Strahan ME; Norman KW; Watkins DN; Sturm MJ; Taylor RR J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]